A Study of E7820 in People With Bone Marrow (Myeloid) Cancers

NCT05024994 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Myelodysplastic Syndromes
Chronic Myelomonocytic Leukemia

Interventions

DRUG: E7820

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]